Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
October 22, 2014
Accelerated molecular dynamics and protein conformational change: a theoretical and practical guide using a membrane embedded model neurotransmitter transporter
Patrick C Gedeon, James R Thomas, Jeffry D Madura
Proteins
|
April 23, 2014
Structural dynamics of the monoamine transporter homolog LeuT from accelerated conformational sampling and channel analysis
James R Thomas, Patrick C Gedeon, Jeffry D Madura
Proteins
|
November 10, 2009
Molecular dynamics of leucine and dopamine transporter proteins in a model cell membrane lipid bilayer
Patrick C Gedeon, Martín Indarte, Christopher K Surratt, et al.
Drugs of the Future
|
February 10, 2015
Rindopepimut: anti-EGFRvIII peptide vaccine, oncolytic
Patrick C Gedeon, Bryan D Choi, John H Sampson, et al.
Biophysical Journal
|
July 26, 2012
LeuT conformational sampling utilizing accelerated molecular dynamics and principal component analysis
James R Thomas, Patrick C Gedeon, Barry J Grant, et al.
Cancer Cell
|
December 25, 2025
Targeting STING to generate therapeutic anti-tumor immunity
Caroline G Fahey, Anthony F Cordova, Patrick C Gedeon, et al.
Seminars in Oncology
|
September 1, 2014
Antibody-based immunotherapy for malignant glioma
Patrick C Gedeon, Katherine A Riccione, Peter E Fecci, et al.
The Journal of Physical Chemistry. B
|
June 18, 2016
Structure and Dynamics Study of LeuT Using the Markov State Model and Perturbation Response Scanning Reveals Distinct Ion Induced Conformational States
Eliana K Asciutto, Patrick C Gedeon, Ignacio J General, et al.
Oncoimmunology
|
January 30, 2014
Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody
Bryan D Choi, Patrick C Gedeon, Luis Sanchez-Perez, et al.
Journal for Immunotherapy of Cancer
|
April 11, 2020
First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach
Teilo H Schaller, David J Snyder, Ivan Spasojevic, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Methods in Molecular Biology (Clifton, N.J.)
|
October 22, 2014
Accelerated molecular dynamics and protein conformational change: a theoretical and practical guide using a membrane embedded model neurotransmitter transporter
Patrick C Gedeon, James R Thomas, Jeffry D Madura
Proteins
|
April 23, 2014
Structural dynamics of the monoamine transporter homolog LeuT from accelerated conformational sampling and channel analysis
James R Thomas, Patrick C Gedeon, Jeffry D Madura
Proteins
|
November 10, 2009
Molecular dynamics of leucine and dopamine transporter proteins in a model cell membrane lipid bilayer
Patrick C Gedeon, Martín Indarte, Christopher K Surratt, et al.
Drugs of the Future
|
February 10, 2015
Rindopepimut: anti-EGFRvIII peptide vaccine, oncolytic
Patrick C Gedeon, Bryan D Choi, John H Sampson, et al.
Biophysical Journal
|
July 26, 2012
LeuT conformational sampling utilizing accelerated molecular dynamics and principal component analysis
James R Thomas, Patrick C Gedeon, Barry J Grant, et al.
Cancer Cell
|
December 25, 2025
Targeting STING to generate therapeutic anti-tumor immunity
Caroline G Fahey, Anthony F Cordova, Patrick C Gedeon, et al.
Seminars in Oncology
|
September 1, 2014
Antibody-based immunotherapy for malignant glioma
Patrick C Gedeon, Katherine A Riccione, Peter E Fecci, et al.
The Journal of Physical Chemistry. B
|
June 18, 2016
Structure and Dynamics Study of LeuT Using the Markov State Model and Perturbation Response Scanning Reveals Distinct Ion Induced Conformational States
Eliana K Asciutto, Patrick C Gedeon, Ignacio J General, et al.
Oncoimmunology
|
January 30, 2014
Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody
Bryan D Choi, Patrick C Gedeon, Luis Sanchez-Perez, et al.
Journal for Immunotherapy of Cancer
|
April 11, 2020
First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach
Teilo H Schaller, David J Snyder, Ivan Spasojevic, et al.
Page
of 3